Add the specialty areas of your choice to tailor excemed.org to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

You have an old EXCEMED account ...

Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?

... or you lost your password?

Learning Package: Cardiovascular risks

Learning Package: Cardiovascular risks
  • Cardiometabolic
  • Hypertension
Announcement
5 December 2017

Take a fresh look at the evidence on specific and relevant topics related to cardiovascular disease. Review the following learning resources to grasp topics, including:

  • Sympathetic nervous system over activity as a pathogenetic mechanism in hypertensive-related cardiovascular risk and discuss if  this  parameter  can  be  considered  a  target  in  antihypertensive treatment
  • The  role  of  fixed  dose  combinations  in  the  treatment  of hypertension and address the therapeutic relevance of the new fixed dose combination beta-blocker/calcium antagonist
  • Best  practice  according  to  guidelines  for  treating hypertensive patients with coronary artery disease
  • Complex transition from hypertension to heart failure and  discuss  the  possible  beneficial  effect  of  pharmacological treatment
  • The best beta-blocker compound when treating patients with diabetes

Sympathetic nervous system and cardiovascular risk

                            G. Mancia (Italy)

Should increased heart rate be considered a target in cardiovascular treatment?

                            H. A.J. Struijker-Boudier (The Netherlands)

New possibilities for the fixed-dose combination treatment in hypertension

                            S. Taddei (Italy)

Best practice in the management of stable chronic angina

                            B. Tomlinson (Hong Kong)    

From hypertension to heart failure: prevention strategies

                            E. Erdmann (Germany)

Use of betablockers in diabetes

                            G. Grassi (Italy)

The role of beta-blockers in hypertensive patients

                             H. A.J. Struijker-Boudier (The Netherlands)

How to optimize treatment in patients with heart failure

                             E. Erdmann (Germany)

 

 

 

Regional workshop
Lisbon, Portugal
Nov 18, 2017
Target audience
Cardiologists and internists involved in preventing and managing patients with cardiovascular risk factors or who are experiencing cardiovascular diseases.
EBAC
by Excemed
Cardiometabolic